Please assess the completion status of the following clinical trial:

Trial Title: Clinical Trial Corticoids For Empyema And Pleural Effusion In Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients between 1 and 14 year old.~* Presence of pneumonia diagnosed by clinical and radiographic criteria: cough, fever and radiological consolidation.~* Evidence of pleural effusion.~Exclusion Criteria:~* Allergy to any of the drugs included in the study.~* Immunodeficiency.

- Gender: ALL
- Minimum Age: 1 Month
- Maximum Age: 14 Years
- Healthy Volunteers: f

Study Arms:
- Dexamethasone (Type: EXPERIMENTAL): * Dexamethasone 0,25mg/kg, IV, q.i.d. for 2 days.~* Cefotaxime 200 mg/kg, IV, q.d. until discharge criteria are present~* Ranitidine 5 mg/kg IV, q.d. for 2 days~* Amoxicillin/Clavulanic acid orally (80mg/kg/day) during 15 days.
- Placebo (Type: PLACEBO_COMPARATOR): Normal saline 0,6 ml/kg, IV, q.i.d. for 2 days.~* Cefotaxime 200 mg/kg, IV, q.d. until discharge criteria are present.~* Ranitidine 5 mg/kg IV, q.d. for 2 days.~* Amoxicillin- Clavulanic acid 80mg/kg p.o., q.d. during 15 days.

Based on this trial design, predict the completion outcome and termination type (if applicable).